federal pharmacy compliance
Stop 1900 Federal Problem Reports Expose One Semaglutide Oversight
1,700 federal problem reports stem from a single missed verification step in the semaglutide compounding workflow. The oversight occurs when pharmacies skip the mandatory sponsor-license alignment check before labeling each batch, allowing errors to cascade through the supply chain. Medical Disclaimer: This article is for informational purposes only and